Selective Electrical Silencing of Mammalian Neurons In Vitro by the Use of Invertebrate Ligand-Gated Chloride Channels by Slimko, Eric M. et al.
Selective Electrical Silencing of Mammalian Neurons In Vitro by the
Use of Invertebrate Ligand-Gated Chloride Channels
Eric M. Slimko,1 Sheri McKinney,2 David J. Anderson,2 Norman Davidson,2 and Henry A. Lester2
1Computation and Neural Systems Program and 2Division of Biology, California Institute of Technology, Pasadena,
California 91125
Selectively reducing the excitability of specific neurons will (1)
allow for the creation of animal models of human neurological
disorders and (2) provide insight into the global function of
specific sets of neurons. We focus on a combined genetic and
pharmacological approach to silence neurons electrically. We
express invertebrate ivermectin (IVM)-sensitive chloride chan-
nels (Caenorhabditis elegans GluCl  and ) with a Sindbis virus
and then activate these channels with IVM to produce inhibition
via a Cl conductance. We constructed a three-cistron Sindbis
virus that expresses the  and  subunits of a glutamate-gated
chloride channel (GluCl) along with the green fluorescent pro-
tein (EGFP) marker. Expression of the C. elegans channel does
not affect the normal spike activity or GABA/glutamate postsyn-
aptic currents of cultured embryonic day 18 hippocampal neu-
rons. At concentrations as low as 5 nM, IVM activates a Cl
current large enough to silence infected neurons effectively.
This conductance reverses in 8 hr. These low concentrations of
IVM do not potentiate GABA responses. Comparable results
are observed with plasmid transfection of yellow fluorescent
protein-tagged (EYFP) GluCl  and cyan fluorescent protein-
tagged (ECFP) GluCl . The present study provides an in vitro
model mimicking conditions that can be obtained in transgenic
mice and in viral-mediated gene therapy. These experiments
demonstrate the feasibility of using invertebrate ligand-
activated Cl channels as an approach to modulate excitability.
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This paper focuses on an approach to understanding the role of
individual neuronal cell types in development, information pro-
cessing, and behavior. Several investigators have suggested that
such information can be obtained by using gene transfer in vitro,
or transgenic animals, to produce spatially and temporally con-
trolled inactivation of specific neurons (White et al., 2001a).
Recent studies report the use of transcriptional induction of
various K channels (Johns et al., 1999; Falk et al., 2001), and
this method silences Drosophila neurons or muscle in vivo (Para-
dis et al., 2001; White et al., 2001b; Nitabach et al., 2002),
providing useful insights into the role of defined neuronal popu-
lations. We previously studied the possibilities for neuronal si-
lencing by using expressed G-protein-gated inwardly rectifying
K (GIRK) channels (Ehrengruber et al., 1997), weakly inwardly
rectifying K channels (Nadeau et al., 2000), and neuron-
restrictive silencing factor (Nadeau and Lester, 2002). However,
there are indications that K channels may cause unwanted side
effects, such as apoptosis caused by sustained K efflux, in the
cultured mammalian CNS neurons that were used to test this
strategy (Nadeau et al., 2000).
The emerging genetic techniques seem to present some advan-
tages over previous exclusively pharmacological strategies. Target
areas and nuclei indeed have been inactivated in vivo via the focal
application of a GABA agonist, muscimol (Jasnow and Huhman,
2001; Maren et al., 2001). This procedure has been valuable in
determining the role of the amygdala and hippocampus in fear
conditioning (Helmstetter and Bellgowan, 1994; Muller et al.,
1997; Holt and Maren, 1999; Wilensky et al., 1999, 2000). How-
ever, the muscimol strategy suffers from limitations such as the
inability to know exactly which neurons were silenced, the inabil-
ity to silence specific cell types in a given brain region, the
inability to silence distributed but functionally related neuronal
populations, and the irreproducible localization of focal injec-
tions. Also, specific neuronal populations have been ablated irre-
versibly (Kobayashi et al., 1995; Sawada et al., 1998; Watanabe et
al., 1998; Isles et al., 2001), but further insights could arise from
a reversible technique.
We suggest a strategy that combines the genetic and acute
pharmacological manipulations. Because GABA and glycine are
the major inhibitory neurotransmitters in the brain and because
GABAA and glycine receptors inhibit activity by activating a Cl

conductance, we have explored the possibility of using ligand-
activated Cl channels as silencing genes. The glutamate-gated
chloride channel (GluCl) family of ligand-gated Cl channels,
found in several invertebrate phyla, is the target for various
pesticides, anthelminthic, and antiparasitic drugs, including iver-
mectin (IVM) (Cully et al., 1994). GluCl channels are part of the
nicotinic receptor superfamily, characterized by four transmem-
brane segments and a large N terminus, and are most similar to
GABAA and glycine receptors. Glutamate is the putative in vivo
ligand for these channels. No GluCl channels have been detected
yet in mammals (Martin et al., 1998; Xue, 1998).
The GluCl channels may represent a promising set of silencing
genes. We have used a recombinant Sindbis virus to express these
channels in cultured neurons and then tested whether the ex-
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pressed channels can be activated with high sensitivity and high
selectivity by IVM. Indeed, we do find that IVM at low nano-
molar concentrations induces a large Cl conductance in some
infected neurons, effectively clamping the membrane at a poten-
tial near the original resting potential. As a result, neither current
injection nor focal application of excitatory transmitter elicits
action potentials. We also studied possible unwanted additional
effects of either GluCl channel expression or IVM application
and found these potential side effects to be minimal or nonexist-
ent. The inducible and reversible nature of this inactivation,
which we term the GluCl/IVM method, represents a potential
powerful new technique for use in probing the contributions of
specific regions of the nervous system to the global function.
MATERIALS AND METHODS
Viral vectors and preparation. Wild-type Caenorhabditis elegans GluCl 
and GluCl  genes (Cully et al., 1994) cloned into pBluescript II SK
were a kind gift from Merck Research Laboratories (Whitehead, NJ); the
Sindbis vector pSinRep5dsgEGFP was a kind gift from Drs. H. Nawa and
M. Kawamura of Niigata University (Niigata, Japan). The oligos pSG1
(5-6CG ACG TCA TCT CTA CGG TGG TCC TAA ATA GTT TAA
ACG CAT G –3) and pSG2 (5-6CG TTT AAA CTA TTT AGG ACC
ACC GTA GAG ATG ACG TCG CAT G-3) were annealed and ligated
into the SphI site of pSinRep5dsgEGFP, resulting in pSinRep5tsgEGFP.
GluCl  was amplified by PCR with the primers 5-ATA GAT ACG CGT
TCA ATA CTG CAT AAA T-3 and 5-TAG ATT CAC GTG AAA
GCA TTC TCG ATC A-3 and cloned into the MluI and AatII sites of
pSinRep5tsgEGFP, resulting in pSinRep5tsgGluC lEGFP. GluC l
 was amplified by PCR with the primers 5-AAT GCA GCA TGC
ACT ACA CCT AGT TCA T-3 and 5-ACC GGT GCA TGC TAT
GAT GTT TGC AAA T-3 and cloned into the SphI site of
pSinRep5tsgGluClEGFP, resulting in pSinRep5tsgGluClEGFP
(Fig. 1). Then this plasmid was used to generate recombinant Sindbis
virus according to the manufacturer’s instructions. Briefly, RNA was
transcribed from this plasmid and the DB-26S helper plasmid by using
the Invitrogen InvitroScript kit (Carlsbad, CA). These two RNA
species were transfected by electroporation into baby hamster kidney
cells and incubated for 48 hr. The supernatant was collected and
filtered at 0.2 m, and the viral particles (termed vSinGluClEGFP)
were concentrated by centrifugation at 35,000 rpm for 1 hr.
Neuronal culture. Rat embryonic day 18 (E18) hippocampal neurons
were prepared as described previously (Li et al., 1998). Hippocampal
cultures then were infected with 1–5 l of the above virus stocks per 35
mm culture dish containing 2 ml of medium. Neurons were infected
after 12–16 d in culture, and recordings were made 24–48 hr later. For
neuron transfection experiments, Lipofectamine 2000 from Invitrogen
was used in conjunction with Nupherin-neuron from Biomol Research
Laboratories (Plymouth Meeting, PA) per the manufacturer’s instruc-
tions. Briefly, 5 g of DNA of each tagged subunit was incubated with
120 g of Nupherin-neuron in 400 l of Neurobasal medium without
phenol red while 10 l of Lipofectamine 2000 was mixed in 400 l of
Neurobasal. After 15 min the two solutions were combined and incu-
bated for 45 min. Neuronal cultures in 35 mm culture dishes were
incubated in the resulting 800 l mixture for 5 min, spun in a swinging
bucket centrifuge at 1000 rpm for 5 min, and incubated for 4 hr; then the
mixture was removed and replaced with the original 2 ml medium.
Recordings were made 24–48 hr later.
Electrophysiology. The bath solution contained (in mM): 110 NaCl, 5.4
KCl, 1.8 CaCl2, 0.8 MgCl2, 10 HEPES, and 10 D-glucose, pH 7.4, with an
osmolarity of 230 mOsm. Patch pipettes were filled with a solution
containing (in mM): 100 K-gluconate, 0.1 CaCl2, 1.1 EGTA, 5 MgCl2, 10
HEPES, 3 ATP, 3 phosphocreatine, and 0.3 GTP, pH 7.2, at 215 mOsm.
Whole-cell voltage clamp was maintained by using an Axopatch-1D
amplifier controlled by a personal computer running pClamp 8 software
via a Digidata 1200 interface (Axon Instruments, Foster City, CA). Data
were filtered at 2 kHz and digitized at 5 kHz. Drugs were applied focally
to single voltage- and current-clamped neurons by using a Picospritzer
with a U-tube system providing the wash (Khakh et al., 1995).
Statistics. Pooled data are shown as means  SEM.
RESULTS
Initial experiments were performed on transfection of the GluCl
 and  subunits into human embryonic kidney (HEK) cells.
Robust responses to IVM (500 nM) were detected only in cells
that expressed both the  and  subunits (Fig. 2A,B). Unlike
recordings from Xenopus oocytes (Cully et al., 1994), the current
was transient; however, when we used successive voltage ramps to
measure the conductance and reversal potential of the current, we
found that the conductance remained relatively constant and the
reversal potential changed after the application of IVM (Fig.
2C,D). In experiments that are not shown, we found that the
IVM-induced conductance was stable for at least 30 min. These
results encouraged us to design and construct the Sindbis virus,
vSinGluClGFP, which expressed three genes: GluCl,
GluCl, and green fluorescent protein (GFP) as a reporter for
infected cells.
The GluCl/IVM method suppresses
neuronal excitability
We infected 10- to 14-d-in-culture rat E18 hippocampal cultures
with vSinGluClGFP or the control virus vSinEGFP. As ex-
pected from previous studies (Khakh et al., 2001), the cultures
were infected readily by either Sindbis virus, showing robust GFP
expression in 20–50% of the neurons as early as 6 hr after
infection. Previous studies also show that Sindbis-infected neu-
rons die after 48 hr, presumably because the virus recruits all of
the ribosomes of the cell and thereby effectively shuts off host
Figure 1. Modified pSinRep5 construct, pSinRep5tsgGluClEGFP,
designed to express three genes with three subgenomic promoters: the
GluCl  subunit, the GluCl  subunit, and the reporter EGFP. The
resulting Sindbis virus is vSinGluClEGFP.
Figure 2. Both GluCl  and  are required for functional channels in
HEK 293 cells. A, Voltage-clamp record of a HEK 293 cell transfected
with GluCl  and EGFP shows that this subunit alone does not respond
to applications of 500 nM IVM. Five of five cells showed no response to
this subunit alone. B, Voltage-clamp record of a HEK 293 cell transfected
with GluCl  and  subunits shows a transient IVM-induced current. Five
of five cells transfected in this manner showed a robust response to IVM.
C, Voltage ramps from –90 to –40 mV before (arrow), during, and after
the application of 500 nM IVM. The increasing slopes show the IVM-
induced conductance. The waveforms also show a clear change in reversal
potential during the development of the conductance. Ramps 100 msec in
duration were delivered at 1 sec intervals. D, Input resistance of the cell
in C. A conductance develops and then remains relatively constant after
the application of IVM.
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protein synthesis (Frolov and Schlesinger, 1994; Perri et al.,
2000); therefore, we performed our experiments at 24 hr after
infection. Neurons that were infected with vSinGluClGFP
and vSinEGFP had morphology indistinguishable from unin-
fected controls at this stage and appeared to be healthy (data not
shown).
In 20% of GFP-positive cells that were infected with
vSinGluClGFP, we detected a robust conductance increase
with the application of 5–500 nM IVM (Fig. 3A–C, bottom panels).
The time to activate this current was dose-dependent; the time
constant decreased from 500 sec at 5 nM to 6 sec at 500 nM.
Surprisingly, the maximal conductance did not seem to vary in
this concentration range. Also shown in the top panels of Figure
3 is the robust silencing effect of this conductance increase.
Spontaneously firing cells subject to the application of IVM
stopped firing action potentials, and the membrane potential
moved to values between –50 and –65 mV, which is near the value
of ECl for the solutions that we used. Importantly, vSinEGFP-
infected neurons and uninfected neurons showed no responses to
IVM at these concentrations (data not shown).
Glutamate is the major excitatory transmitter in the brain, and
brief applications of glutamate strongly elicit action potentials in
hippocampal neurons (Storm-Mathisen, 1981; Crunelli et al.,
1983). The major goal of the GluCl/IVM method is to insure
that, once a GluCl-positive cell is activated by IVM, it no
longer fires action potentials in response to excitatory input.
Figure 4A demonstrates this effect. The left panel shows that an
infected neuron fires volleys of action potentials in response to 10
msec pulses of 100 M glutamate; the right panel shows that, in
the presence of 5 nM IVM, the same neuron no longer responds
to identical glutamate pulses. Below (see Fig. 8), we show that
neurons expressing this invertebrate glutamate receptor display
no changes in glutamate responses.
Additionally, neurons that are infected with vSinGluClGFP
and activated with IVM show extreme reductions in impulse
firing elicited by direct current injection. The top panel of Figure
4B shows current-clamp records from a vSinGluClGFP-
infected neuron. Increasing current pulses (up to 30 pA) elicit
current-dependent firing. The bottom panel shows records from a
similar neuron, incubated with 5 nM IVM. This neuron does not
respond at all to the same current injection protocol. Moreover,
injection of up to 200 pA (data not shown) failed to elicit a spike.
Figure 4C shows the same experiments for an uninfected control
cell; 5 nM IVM did not affect the excitability. This lack of IVM
effect was observed in all of 103 uninfected or 55 vSinEGFP-
infected neurons, respectively.
Sindbis expression produces highly variable results
Previous reports show large cell-to-cell variability in expression
levels, based on measurements that used dual promoters to ex-
press an ion channel subunit with the Sindbis virus (Okada et al.,
2001). We expected similar cell-to-cell variability in our experi-
ments. Unexpectedly, we found that the major variability in IVM
responses occurred between culture dishes rather than within
neurons in a given culture (Fig. 5). Each point in Figure 5
represents the average of five infected neurons in a single infected
culture. Some cultures respond well, whereas others do not. We
could observe no clear morphological differences or GFP fluo-
rescence intensity differences between cultures that expressed
well and those that expressed poorly. We attempted, with no
success, to minimize this variability by varying the age of the
cultures, the time after infection, temperature and position in the
incubator, preparation of the virus, sonication of the virus, and
glutamate concentration in the culture medium. In control dishes
that were infected with vSinEGFP, there was no significant dif-
ference between the IVM and IVM input conductance in any
culture that was tested (data not shown). Because of this culture-
to-culture variation, we selected only cultures that had neurons
responding well to IVM for the measurement studies presented
above. We found similar dish-to-dish variability in HEK 293
cultures that were infected with vSinGluClEGFP, but not in
HEK cultures transfected with both plasmids encoding the GluCl
Figure 3. Activation of GluCl conductance by IVM over a 100-fold
concentration range (A, 500 nM; B, 50 nM; C, 5 nM). Top panels, Current-
clamp data from cells that displayed spontaneous activity. Bottom panels,
Input conductance measured with voltage-clamp ramps from –80 to –50
mV for 200 msec duration at intervals of 1 sec. Each panel represents data
from a different cell. Uninfected and GFP-infected neurons had no
response to IVM applied similarly.
Figure 4. IVM silences GluCl-expressing neurons. A, Silenced cells no
longer respond to glutamate. Shown are current-clamp traces from a
GluCl-infected cell. Dots indicate 10 msec applications of 100 M gluta-
mate. A, Left, Before activation with IVM the cell responds to glutamate
with action potentials. A, Right, After activation with 5 nM IVM the cell
no longer responds to the same glutamate application. The 1 sec appli-
cations of glutamate could produce a slight depolarization, but no action
potentials (data not shown). B, GluCl-infected cells in current clamp,
showing responses to depolarizing current pulses (0–30 pA, 5 pA incre-
ments). In control solutions the cells responded with action potentials, but
the IVM-induced (5 nM) Cl conductance prevented action potentials
(bottom panel ). Cells remained silenced even in responses to current
pulses as high as 200 pA (data not shown). C, An uninfected cell showing
no reduction in excitability by 5 nM IVM.
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subunits; therefore, we believe that this variability is a character-
istic of the Sindbis expression system rather than an inherent
limitation of the GluCl/IVM method.
In Nupherin-mediated transfection, all fluorescent cells
respond to IVM
We sought an expression method that could overcome the vari-
ability of the Sindbis system. We used the newly developed
Nupherin-neuron transfection system to transfect GluCl channels
into hippocampal cultures. In these experiments we modified the
GluCl coding sequence to include fluorescent proteins (yellow
fluorescent protein, YFP; cyan fluorescent protein, CFP) in the
M3–M4 loop of each construct (GluCl and  subunits, respec-
tively, as shown in Fig. 6A). Figure 6C–E shows images from an
exemplar hippocampal culture. Each of 30 fluorescent cells in
three cultures responded to 5 nM IVM with a conductance 30
nS, similar to the results with neurons in responsive Sindbis-
infected cultures (Fig. 6B). This figure shows that neurons trans-
fected with the GluCl  subunit alone do not develop a conduc-
tance in the presence of IVM. The variability between cultures is
substantially less with Nupherin-mediated expression than with
Sindbis-mediated expression.
IVM-induced Cl conductance is reversible
In previous reports IVM has been described as acting irreversibly
on GluCl channels expressed in Xenopus oocytes (Cully et al.,
1994) on a time scale of several minutes. Ligand-binding experi-
ments show that IVM does dissociate from its receptor (presum-
ably the GluCl channels), with a rate constant of 0.005–0.006/min
(Cully and Paress, 1991). Therefore, we sought to measure the
reversibility of IVM action on a time scale of several hundred
minutes. We infected cultures of hippocampal neurons, incubated
in 5 nM IVM, and we measured the input conductance of the
neurons to verify that the channels were activated. We then
washed the cultures and recorded the input conductance after 1
or 8 hr. Figure 7A summarizes these results. At 1 hr the conduc-
tance has not changed significantly from the activated conduc-
tance, whereas by 8 hr the conductance has returned nearly to
baseline. The final bar shows that IVM subsequently can reacti-
vate the channels. Formally, it is not possible to distinguish
between the possibility that the reversibility is caused by IVM
washing off the GluCl receptors or the possibility that the revers-
ibility is attributable to receptor turnover, but the important
feature here is that the technique appears to be reversible in
terms of electrical activity.
Figure 5. There is a large variation in expression levels that seems to be
culture dependent. Each point represents the average of five cells in a
culture dish. Approximately one-half of the cultures that were surveyed
have no response to 500 nM IVM, and these cultures were excluded from
the plot. The points plotted here represent the cultures that do respond to
500 nM IVM. Note that this graph represents data taken at 0 and 5 nM
IVM; the points have been spread out to enhance visualization. The arrow
represents average cell conductance in 0 nM IVM, 100 M muscimol for
comparison.
Figure 6. Neurons cotransfected with separate plasmids encoding
EYFP-tagged GluCl  and ECFP-tagged GluCl  show fluorescence. A,
Diagram indicating that the fluorescent protein was inserted in the
M3–M4 loop of each subunit. B, Measured input conductance of neurons
transfected with the GluCl –EYFP fusion and GluCl –ECFP fusion.
NT, Neurons that have not been transfected; AB, neurons transfected with
both subunits; A, neurons transfected with only the GluCl –EYFP
subunit. All bars represent data from three independent cultures, 10 cells
per culture. C, A bright-field image at 40 showing several neurons, with
arrows indicating three neurons that have been transfected. D, The field of
view in C imaged with an ECFP filter set. E, The field of view in C imaged
with an EYFP filter set.
Figure 7. IVM-induced chloride conductance deactivates several hours
after IVM washout. The input conductance of cells that were infected
with vSinEGFP was measured first without IVM and then in the
presence of 5 nM IVM. After 1 hr of washing there is little recovery in cell
conductance, whereas after 8 hr the conductance returns to uninfected
levels. The last bar shows that IVM-induced conductance can be reacti-
vated. Each bar represents 10 cells in two cultures.
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Neither GluCl expression nor IVM application affects
other synaptic properties
In experiments to examine possible unwanted additional effects of
IVM, we used 5 nM IVM, because this concentration produces
adequate silencing in most neurons. Because of the homology
between GluCl channels and GABAA receptors, we were con-
cerned that one or both of these subunits might heteromultimer-
ize with native GABAA receptor subunits. We therefore com-
pared the amplitude, rise time, and decay time of GABA-evoked
responses. The left panel of Figure 8A shows that these three
parameters do not differ significantly between infected and unin-
fected cells, providing confidence that heteromultimerization
with GABA subunits did not take place or at least had no
functional consequences. After measuring the evoked responses,
we applied 5 nM IVM to these cultures to ensure that these
cultures were expressing the GluCl receptor at high levels.
The GluCl  and  heteromultimer is a glutamate receptor
(Cully et al., 1994). We were concerned that this response might
add to or distort the endogenous glutamate response of the
neuron. The right panel of Figure 8A addresses these concerns in
an experiment that used Sindbis-mediated expression: the gluta-
mate response did not change significantly between uninfected
and GluCl-expressing neurons. As above, we used only cul-
tures that responded well to IVM for these experiments. These
experiments were performed with CsCl in the internal recording
solution and were voltage clamped at –60 mV so that any addi-
tional conductance caused by glutamate activation of GluCl
would result in an increase in amplitude or perhaps an increase in
decay time. In infected cultures that were treated with CNQX
and APV to block endogenous glutamate receptors, we found that
steady application of 10 M glutamate (the estimated steady
concentration of glutamate in CSF) produced no detectable con-
ductance increases (	0.1 nS). Steady application of 2 mM gluta-
mate, however, produced slow, large (30 nS) conductances.
IVM has various effects on other ion channels, including
GABA (Krusek and Zemkova, 1994), P2X2 (Khakh et al., 1999),
and neuronal AChR (Krause et al., 1998). These effects occur
with concentrations of IVM higher than 5 nM. However, we chose
to study what we regard as the most likely side effect, GABA
potentiation, with our desired IVM concentration of 5 nM. Figure
8B presents histograms of the amplitude and decay time of the
GABAergic synaptic miniature IPSCs (mIPSCs) recorded from
uninfected neurons in the presence of the glutamate receptor
blockers CNQX and APV and the Na channel blocker TTX.
Figure 8C presents the same type of data, with the addition of 5
nM IVM in the recording medium. There is no apparent poten-
tiation of GABA receptors at this concentration of IVM.
DISCUSSION
We describe a procedure that combines advantages of genetically
based and pharmacologically based silencing by inhibitory ion
channels. Our results demonstrate that the GluCl/IVM method
modifies neuronal excitability in an inducible and reversible man-
ner. Expression of GluCl alone seems to leave the excitability of
the neuron unaltered, and IVM application to uninfected neu-
rons within the effective range for silencing GluCl-expressing
neurons never produces a detectable conductance. However,
many GluCl-expressing neurons display a reduction in excitability
when exposed to low concentrations of IVM. The reduction in
excitability silences many neurons, and this silencing can be
reversed by 8 hr of washing. These are the desired results of the
GluCl/IVM silencing method.
With the Sindbis virus construct there was an inherently high
level of variability of expression among infected cells. Despite
numerous attempts to understand and control this variability, we
found no parameters to explain it. Both HEK cells transfected
with the GluCl  and  subunits and Xenopus oocytes injected
with RNA for this channel nearly always show expression, rein-
forcing our belief that this variability results from an aspect of
Sindbis viral biology. Nupherin-mediated expression yields more
consistent data, supporting this interpretation. Because our long-
term goal involves transgenic methods to express the GluCl
channels, the variability does not appear to be a source of signif-
icant concern for the GluCl/IVM silencing method.
Neurons expressing the channel at a high level are silenced
strongly by 5 nM IVM. This low concentration is important, for
previous reports show that IVM at considerably higher concen-
trations in the mammalian brain is toxic. Studies done with
radiolabeled IVM in blood–brain barrier-impaired mice indicate
that the toxic concentration of IVM in the brain is 500 nM
(Schinkel et al., 1994), which is two orders of magnitude above
the concentration we are using. This gives us some confidence
that in vivo applications of the GluCl/IVM method may succeed.
A related complexity is the delivery of IVM to the brain. The
blood–brain barrier contains mechanisms, primarily involving
mdr1, that appear to pump IVM out of the brain, and this might
prevent systemically applied IVM from reaching GluCl channels
in the brain. However, a clinically relevant intraperitoneal dose,
0.2 mg/kg, results in 1.5 ng/gm IVM in brain tissue (Schinkel et
al., 1994), or 2 nM. This is very close to the concentration we
believe to be necessary for silencing neurons expressing GluCl.
Perhaps in vivo applications of the GluCl/IVM method will
Figure 8. Expression of GluCl does not alter glutamate- or GABA-
evoked currents. A, Evoked currents were measured in GluCl-infected
and uninfected neurons with 10 msec agonist puffs (100 M GABA, 1 mM
glutamate). The amplitude, rise time, and decay time were measured. The
plot shows these three parameters relative to the measurements in unin-
fected cells. GABA responses are shown on the lef t and glutamate
responses on the right. For each of the two ligands the bars represent data
pooled from 10 cells from two different cultures. B, C, Analysis of GABA
mIPSCs in the absence (B) and presence (C) of 5 nM IVM. The peak
amplitude histogram (top) and decay time histogram (bottom) are shown.
The amplitude data are shown in 10 pA bins, and the decay time data are
shown in 10 msec bins. Note that there is no apparent difference in
histogram shape between the 0 and 5 nM IVM case for either measure-
ment. In B, the data are pooled from 20 events each from five neurons in
one culture; in C, the data are pooled from 30 events each from five
neurons in one culture.
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require relatively simple methods of IVM delivery to the animal.
Of course, more sophisticated options exist for easing drug de-
livery, such as using blood–brain disrupting drugs (Jette et al.,
1995) or using mice with disrupted drug pumping at the blood–
brain barrier, as the foundation for transgenic mice expressing
this channel.
Previous reports suggest that IVM “irreversibly” activates
GluCl channels, an unusual situation for ligand-gated channels.
The impression of irreversibility may arise from the limited time
scale of previous experiments on Xenopus oocytes or from drug
retention by the large yolk volume of the cells. Data from our
washout experiments (Fig. 7), suggesting reversibility after 8 hr,
are approximately consistent with the disassociation constant
determined in biochemical binding experiments (Cully and Pa-
ress, 1991). Both the onset and recovery from silencing will
depend on the pharmacokinetics of IVM in the animal; for
instance, IVM can be stored in the fat.
In addition to the channel-based silencing strategies noted in
the introductory remarks, other investigators have used genetic
manipulations of synaptic transmission, for instance by using
tetanus toxin (Baines et al., 2001). It is unclear whether tetanus
toxin-based procedures are reversible. Additionally, exogenous
expression of K channels has been used to modulate biochem-
ical signaling pathways in HEK 293 cells (Holmes et al., 1997).
There are several potential applications for the GluCl/IVM
method, or for improved versions, in research and in therapeutics.
One application would involve cell-specific expression of GluCl
channels under the control of appropriate promoter(s). This
strategy may enable genetic manipulation of excitability at se-
lected times in development and in specific regions in the CNS.
The requirement for both the GluCl  subunit and the GluCl 
subunit at first may seem like a complication; however, this gives
the experimenter the flexibility to use different promoters to drive
the two genes so that only neurons in which both promoters are
active will be silenced with the administration of IVM. Addition-
ally, it may be possible to construct viruses with these two genes
that can be used in vivo. Stereotaxic injection of such viruses then
may circumvent the need for promoters that drive expression in
specific brain nuclei. From a clinical standpoint, a targeted and
controlled “excitability modulator” may form the basis for new
treatments of epilepsy, chronic pain, or other diseases arising
from excess neuronal activity. It may be possible to titrate silenc-
ing by varying the dose of IVM.
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